Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023
   Working Capital/Sales(x) 0.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.79 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹105.8 Cr NA -3.5% -44.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹10,965.0 Cr -1.5% -3.4% 43% Stock Analytics
KIRI INDUSTRIES ₹3,552.7 Cr 9.3% 11.5% 56.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,896.9 Cr 1.6% -1.6% -15.8% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,274.8 Cr 19.6% 16.3% 33.5% Stock Analytics
BODAL CHEMICALS ₹838.3 Cr 1.9% 0.3% -18.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-3.5%

-44.1%

SENSEX

1.2%

1.9%

-0.2%


You may also like the below Video Courses